Avalo Therapeutics
AVTX
AVTX
37 hedge funds and large institutions have $148M invested in Avalo Therapeutics in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
12
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BFM
Boothbay Fund Management
New York
|
$2.62M |
| 2 |
State Street
Boston,
Massachusetts
|
$2.12M |
| 3 |
BlackRock
New York
|
$6.97M |
| 4 |
Morgan Stanley
New York
|
$176K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$110K |
